BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9409014)

  • 1. Dosimetry of beta emitting radionuclides for use in balloon angioplasty.
    Fox RA
    Australas Phys Eng Sci Med; 1997 Sep; 20(3):139-46. PubMed ID: 9409014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta dose point kernels for radionuclides of potential use in radioimmunotherapy.
    Prestwich WV; Nunes J; Kwok CS
    J Nucl Med; 1989 Jun; 30(6):1036-46. PubMed ID: 2738686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endovascular beta irradiation for prevention of restenosis using solution radioisotopes: pharmacologic and dosimetric properties of rhenium-188 compounds.
    Knapp FF; Guhlke S; Beets AL; Lin WY; Stabin M; Amols H; Weinberger J
    Cardiovasc Radiat Med; 1999; 1(1):86-97. PubMed ID: 11272362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta radiation and inhibition of recanalization after coil embolization of canine arteries and experimental aneurysms: how should radiation be delivered?
    Raymond J; Leblanc P; Morel F; Salazkin I; Gevry G; Roorda S
    Stroke; 2003 May; 34(5):1262-8. PubMed ID: 12702839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-absorption correction for 32P, 198Au and 188Re stents: dose point kernel calculations versus Monte Carlo.
    Reynaert N; Häfeli UO
    Med Phys; 2001 Sep; 28(9):1883-97. PubMed ID: 11585219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetry calculation for a novel phosphorus-32-impregnated balloon angioplasty catheter for intravascular brachytherapy.
    Yue N; Nath R; Hehrlein C
    Cardiovasc Radiat Med; 1999; 1(4):349-57. PubMed ID: 10828565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endovascular brachytherapy with (192)Ir and (188)Re to treat de novo and recurrent infrainguinal restenoses.
    Wohlgemuth WA; Leissner G; Wengenmair H; Bohndorf K; Kirchhof K
    J Cardiovasc Surg (Torino); 2010 Aug; 51(4):573-8. PubMed ID: 20671642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorbed dose profiles for (32)P, (90)Y, (188)Re, (177)Lu, (153)Sm and (169)Er: radionuclides used in radiosynoviortheses treatment.
    Torres M; Ayra E; Albuerne O; Montano Delgado MA
    Rev Esp Med Nucl; 2009; 28(4):188-92. PubMed ID: 19922831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-arterial 90Y brachytherapy: preliminary dosimetric study using a specially modified angioplasty balloon.
    Popowski Y; Verin V; Papirov I; Nouet P; Rouzaud M; Schwager M; Urban P; Rutishauser W; Kurtz JM
    Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):713-7. PubMed ID: 7558963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Internal dosimetry for radiation therapy in coronary arteries.
    Compos L; Stabin M
    Radiat Prot Dosimetry; 2002; 101(1-4):423-6. PubMed ID: 12382782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endovascular brachytherapy: dosimetry and dose-area analysis of various radiation sources.
    Boeing N; Geoghegan S; Ebert MA
    Australas Phys Eng Sci Med; 2001 Jun; 24(2):63-70. PubMed ID: 11560172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pure beta-particle-emitting stents inhibit neointima formation in rabbits.
    Hehrlein C; Stintz M; Kinscherf R; Schlösser K; Huttel E; Friedrich L; Fehsenfeld P; Kübler W
    Circulation; 1996 Feb; 93(4):641-5. PubMed ID: 8640989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric comparison of 90Y, 32P, and 186Re radiocolloids in craniopharyngioma treatments.
    Sadeghi M; Karimi E; Hosseini SH
    Med Phys; 2009 Nov; 36(11):5022-6. PubMed ID: 19994512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracoronary beta-irradiation with liquid rhenium-188 to prevent restenosis following pure balloon angioplasty: results from the TRIPPER-1 study.
    Hang CL; Fu M; Hsieh BT; Leung SW; Wu CJ; Ting G
    Chang Gung Med J; 2003 Feb; 26(2):98-106. PubMed ID: 12718386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dosimetry for a coronary artery stent coated with radioactive 188Re and 32P.
    Fox RA; Henson PW
    Phys Med Biol; 2000 Dec; 45(12):3643-55. PubMed ID: 11131190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-stenting intravascular brachytherapy trials on hypercholesterolemic rabbits using 32P liquid sources: implications for prevention of in-stent restenosis.
    Wilczek K; Walichiewicz P; Petelenz B; Jache W; Jochem J; Tomasik A; Bilski P; Snietura M; Wodniecki J
    Cardiovasc Intervent Radiol; 2002; 25(4):307-13. PubMed ID: 12042990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dosimetry fundamentals of endovascular therapy using Re-188 for the prevention of restenosis after angioplasty].
    Kotzerke J; Rentschler M; Glatting G; Schneider E; Stabin M; Knapp FF; Reske SN
    Nuklearmedizin; 1998 Mar; 37(2):68-72. PubMed ID: 9547753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel balloon angioplasty catheter impregnated with beta-particle emitting radioisotopes for vascular brachytherapy to prevent restenosis; first in vivo results.
    Hehrlein C; Kovacs A; Wolf GK; Yue N; Nath R
    Eur Heart J; 2000 Dec; 21(24):2056-62. PubMed ID: 11102256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetry of beta sources in radiotherapy I. The beta point source dose function.
    Vynckier S; Wambersie A
    Phys Med Biol; 1982 Nov; 27(11):1339-47. PubMed ID: 7178234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calculation of beta dosimetry in radiation synovectomy using Monte Carlo simulation (EGS4).
    Johnson LS; Yanch JC
    Med Phys; 1993; 20(3):747-54. PubMed ID: 8350831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.